ClinicalTrials.gg
Sign In

Neuritis clinical trials

The registry lists 73 studies for Neuritis across more than 10 countries. 20 are recruiting or about to start. 34 of them are mainly about Neuritis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-02.

Get an email when these change. Save the Neuritis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
32
Recruiting
14
Status unknown
10
Terminated
7
Not yet recruiting
6
Active, not recruiting
2

Phase

Phase 2
11
Phase 3
4
Phase 1
4
Early Phase 1
3
Phase 4
2

Where

United States
27
Egypt
8
France
7
China
5
Brazil
4
United Kingdom
4

Who runs them

Erchonia Corporation (2) · University of Aarhus (2) · University of Rochester (2) · Tanta University (2) · Sahlgrenska University Hospital (2) · Istanbul University (2) · Cairo University (2) · Fondation Ophtalmologique Adolphe de Rothschild (2)

What is being tested here

Drugs under test in Neuritis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Panzyga101
Ketotifen111
Acalabrutinib001
Saposin C (non-glycosylated)001
Capsaicin011
Nerispirdine001
Dexamethasone001
CNM-Au8001
Lacosamide001
TACI receptor-IgG Fc fragment fusion protein001

Coming up

2phase 3 studies under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 14 Neuritis studies recruiting now, 11 (79%) set no upper age limit and 1 (7%) stop at 75 or younger. 2 (14%) take children under 18. 1 (7%) are for women only and 0 (0%) for men only; 3 (21%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
102 (14%)1 (7%)
1813 (93%)12 (86%)
3014 (100%)13 (93%)
4014 (100%)13 (93%)
5014 (100%)13 (93%)
6514 (100%)13 (93%)
7514 (100%)13 (93%)
8511 (79%)10 (71%)

Across all 73 studies, recruiting or not: 34% stop at 75 or younger and 25% at 65; 11% take children; 7% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neuritis studies take

Of 23 interventional studies with no phase under Neuritis, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase24 mo10–31 · 23 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 73. Browse all 73 → or search them.